A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
Clinical trial NCT05179603 · TERMINATED
Trial details
- NCT number
- NCT05179603
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2023-09-14
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.